Infliximab Weakens COVID Antibody Response for Patients With IBD
Patients treated with infliximab for inflammatory bowel disease (IBD) showed significantly reduced response to COVID-19 antibodies, compared with those treated […]
» Read moreHome »
Delaying second doses of COVID-19 vaccines should reduce case numbers in the near term. But the longer-term case burden and […] Women who are overweight or obese have up to twice the risk of developing colorectal cancer before age 50 as […]
Delaying second doses of COVID-19 vaccines has benefits, but longer-term results rely on robust immunity
Obesity linked to increased risk of early-onset colorectal cancer
